*In a 72-week study of adults without diabetes, average weight loss was 15.0% (34 lbs) for 5mg, 19.5% (44 lbs) for 10mg, 20.9% (48 lbs) for 15 mg, and 3.1 (7 lbs) for placebo
With the shortage officially resolved, the legal pathway for compounded tirzepatide narrowed considerably
GLP-1s can be expensive, but many insurance plans now cover them for patients who qualify
Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act | FDA
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial
If constipation persists beyond 8 weeks despite hydration and fiber increases, contact your prescriberthis may signal the need for dose adjustment or medication review